News
February 2006 - Ariston merged with Pyrenees Pharmaceuticals, Inc. bringing into the Ariston pipeline two clinical stage compounds, AST-117 for anxiety and AST-914 for movement disorders.
February 2006 - Ariston merged with Pyrenees Pharmaceuticals, Inc. bringing into the Ariston pipeline two clinical stage compounds, AST-117 for anxiety and AST-914 for movement disorders.